LIAKOULI, Vasiliki
 Distribuzione geografica
Continente #
EU - Europa 97
NA - Nord America 45
AS - Asia 25
AF - Africa 1
Totale 168
Nazione #
IE - Irlanda 44
US - Stati Uniti d'America 44
IT - Italia 29
FR - Francia 20
VN - Vietnam 20
DE - Germania 2
GB - Regno Unito 2
IR - Iran 2
EG - Egitto 1
KZ - Kazakistan 1
MX - Messico 1
SG - Singapore 1
TR - Turchia 1
Totale 168
Città #
Dublin 44
Dong Ket 20
Ashburn 19
L'aquila 14
Boardman 7
Paris 4
Avezzano 3
Rome 3
Washington 3
Bremen 2
Pescara 2
San Jose 2
Trieste 2
Alexandria 1
Astana 1
Basking Ridge 1
Bedford 1
Borehamwood 1
Brooklyn 1
Casalbordino 1
Chicago 1
Chihuahua City 1
Fleming Island 1
Jacksonville 1
L’Aquila 1
Montorio al Vomano 1
Tehran 1
Totale 139
Nome #
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling, file e2188bfb-3db3-f28d-e053-d805fe0ac2bb 41
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy, file e2188bfa-e45b-f28d-e053-d805fe0ac2bb 19
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis, file e2188bfb-7a6a-f28d-e053-d805fe0ac2bb 16
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers, file e2188bfa-1416-f28d-e053-d805fe0ac2bb 14
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands, file e2188bfa-ed66-f28d-e053-d805fe0ac2bb 14
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts, file e2188bfb-77f9-f28d-e053-d805fe0ac2bb 14
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study, file e2188bfa-02aa-f28d-e053-d805fe0ac2bb 13
The Role of IL-1β in the Bone Loss during Rheumatic Diseases, file e2188bfb-604f-f28d-e053-d805fe0ac2bb 10
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor, file e2188bfb-6147-f28d-e053-d805fe0ac2bb 10
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy., file e2188bf9-364a-f28d-e053-d805fe0ac2bb 6
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist., file e2188bfb-6622-f28d-e053-d805fe0ac2bb 5
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers, file e2188bfa-2367-f28d-e053-d805fe0ac2bb 2
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features., file e2188bfa-eb64-f28d-e053-d805fe0ac2bb 2
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI)., file e2188bf9-38ce-f28d-e053-d805fe0ac2bb 1
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management., file e2188bfb-5aaf-f28d-e053-d805fe0ac2bb 1
Totale 168
Categoria #
all - tutte 367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 3 0 0 0
2020/202122 1 0 0 0 0 0 0 0 1 0 0 20
2021/20227 0 0 1 0 0 0 0 1 0 1 3 1
2022/2023100 2 1 3 0 4 4 4 3 46 1 31 1
2023/202429 1 0 1 1 0 1 11 12 2 0 0 0
Totale 168